Immunotherapy Combo Boosts Survival in Mouse Models of Mesothelioma, Study Finds – Immuno-Oncology News
Immuno-Oncology News |
Immunotherapy Combo Boosts Survival in Mouse Models of Mesothelioma, Study Finds
Immuno-Oncology News Mesothelin — a protein highly expressed in many human cancers, including malignant mesothelioma, and pancreatic and ovarian cancer — is an attractive target for cancer immunotherapy. VIC-008, also called Jantibody, is a fusion protein that binds to … |
